Cargando…
Integrase deficient lentiviral vector: prospects for safe clinical applications
HIV-1 derived lentiviral vector is an efficient transporter for delivering desired genetic materials into the targeted cells among many viral vectors. Genetic material transduced by lentiviral vector is integrated into the cell genome to introduce new functions, repair defective cell metabolism, and...
Autores principales: | Yew, Chee-Hong Takahiro, Gurumoorthy, Narmatha, Nordin, Fazlina, Tye, Gee Jun, Wan Kamarul Zaman, Wan Safwani, Tan, Jun Jie, Ng, Min Hwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377332/ https://www.ncbi.nlm.nih.gov/pubmed/35979475 http://dx.doi.org/10.7717/peerj.13704 |
Ejemplares similares
-
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
por: Gurumoorthy, Narmatha, et al.
Publicado: (2022) -
Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through
por: Jusop, Amirah Syamimi, et al.
Publicado: (2023) -
Immunomodulation and Regenerative Capacity of MSCs for Long-COVID
por: Loke, Xin Ya, et al.
Publicado: (2021) -
MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022) -
CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
por: Chan, Ler Yie, et al.
Publicado: (2022)